Market Research Logo

France Pharmaceuticals & Healthcare Q1 2019


Attention: There is an updated edition available for this report.

France Pharmaceuticals & Healthcare Q1 2019

Key View:

The upcoming introduction of a series of measures aimed at boosting France’s health industries competitiveness bodeswell for drugmakers operating in the country. In fact, the government’s recent commitments towards accelerating marketauthorisation of innovative medicines, as well as optimising market access and promoting innovation and clinical research,anticipate an effort to transform France into a highly attractive market for drugmakers and investors, reversing the loss ofcompetitiveness of recent years.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Ipsen
Merck & Co
Novartis
Sanofi
Servier
France Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook